SCI Abstract

search
+
High-Frequency Ultrasound in Hidradenitis Suppurativa: From Lesion Detection to Iconographic Lesion-Level Management
High-Frequency Ultrasound in Hidradenitis Suppurativa: From Lesion Detection to Iconographic Lesion-Level Management
Hidradenitis suppurativa is a chronic recurrent inflammatory disease in which conventional clinical examination frequently...
Transforming Outcomes in Advanced Basal Cell Carcinoma: The Evolving Role of Systemic Therapy
Transforming Outcomes in Advanced Basal Cell Carcinoma: The Evolving Role of Systemic Therapy
Advanced basal cell carcinoma (aBCC) is an uncommon but severe presentation of basal cell carcinoma, including those with ...
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium
Genital psoriasis remains underdiagnosed and undertreated despite its substantial impact on quality of life. The sensitive...
Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Melanoma is an aggressive skin cancer with limited durable responses despite therapeutic advances. Comprehensive character...
Dermatologic Toxicities Induced by JAK Inhibitors
Dermatologic Toxicities Induced by JAK Inhibitors
Janus kinase inhibitors are increasingly used for the treatment of a wide range of dermatologic and non-dermatologic immun...
Evaluating the Performance of Artificial Intelligence in Accurately Detecting Skin Cancer: An Umbrella Review of Systematic Reviews and Meta-analyses
Evaluating the Performance of Artificial Intelligence in Accurately Detecting Skin Cancer: An Umbrella Review of Systematic Reviews and Meta-analyses
Artificial intelligence technology is being widely developed in dermatology. However, there remains a lack of comprehensiv...
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study
Ruxolitinib cream (1.5%) has demonstrated efficacy and safety in patients aged ≥ 2 years with mild-to-moder...
: Rise, Diagnosis, Treatment, and Future Directions
: Rise, Diagnosis, Treatment, and Future Directions
Dermatophytoses (synonymous with tinea) are superficial fungal infections of the skin, hair, and nails, typically caused b...
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias
Porphyrias are rare metabolic disorders caused by inherited or acquired enzymatic defects in the heme biosynthesis pathway...
Dermatologic Adverse Events Associated with T-Cell Engager Therapy
Dermatologic Adverse Events Associated with T-Cell Engager Therapy
T-cell engager therapies, including bispecific T-cell engagers and the immune-mobilizing monoclonal T-cell receptor agains...
Practical Therapeutic Strategies for Acne-Induced Hyperpigmentation Across all Skin Types
Practical Therapeutic Strategies for Acne-Induced Hyperpigmentation Across all Skin Types
Post-inflammatory hyperpigmentation and post-inflammatory erythema are common sequelae of acne, particularly affecting ind...
Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management
Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management
Primary cutaneous cryptococcosis (PCC) is a rare, localized fungal infection caused by Cryptococcus species, typically fol...
What’s New in Photoprotection?
What’s New in Photoprotection?
It is well established that a complete package of photoprotection includes staying in the shade, wearing photoprotective c...
A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa
A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease which imposes a significant burden in terms of pain, ...
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions
Head and neck atopic dermatitis represents a common and clinically challenging phenotype of atopic dermatitis, characteriz...
Atopic Dermatitis: New Targets and Emerging Systemic Therapies
Atopic Dermatitis: New Targets and Emerging Systemic Therapies
Atopic dermatitis (AD) is a chronic inflammatory skin disease, driven by barrier and immune dysregulation, which causes si...
Defining the Potential for Disease Modification in Atopic Dermatitis
Defining the Potential for Disease Modification in Atopic Dermatitis
Atopic dermatitis is a common inflammatory disorder affecting the skin, often associated with a strong disease burden and ...
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy
With more than 300,000 new cases diagnosed in 2022 and a projected rise in incidence until the year 2040, malignant melano...
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory dermatosis requiring multifaceted treatment. Poor adherence to topical th...
Defining “Flares” in Atopic Dermatitis: A Narrative Review
Defining “Flares” in Atopic Dermatitis: A Narrative Review
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by fluctuating disease activity. Exacerbatio...
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Upadacitinib is an oral selective Janus kinase inhibitor approved to treat moderate-to-severe atopic dermatitis (AD) in ad...
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry
Atopic dermatitis (AD), a chronic systemic disease, can cause intense skin itching and negatively impact sleep, mood, and ...
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults
Atopic dermatitis (AD) significantly affects quality of life in patients of all ages and requires long-term treatment. Dup...
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma
Data are limited regarding the performance of staging systems for non-head and neck cutaneous squamous cell carcinomas (no...
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
This is a summary of the original article: “Efficacy and safety of delgocitinib cream in adults with moderate to sev...
Understanding Enthesitis in Psoriatic Disease: Insights and Implications
Understanding Enthesitis in Psoriatic Disease: Insights and Implications
Enthesitis represents a hallmark feature and central pathological process in psoriatic arthritis and has been proposed as ...
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials
Differences in atopic dermatitis (AD) prevalence, clinical presentation, and pathophysiology have been reported in differe...
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
Low-dose oral minoxidil has gained recognition as an off-label treatment for hair loss disorders, including androgenetic a...
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review
Acne vulgaris (acne) is a common dermatological condition that can profoundly affect psychosocial well-being. Health-relat...
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
The efficacy and safety of once-daily roflumilast foam 0.3%, a potent phosphodiesterase 4 inhibitor, has been demonstrated...
Load More
format_indent_increase